Private Capital's DMAC Position Overview
Private Capital (via Private Capital Management, LLC) currently holds 50,000 shares of DiaMedica Therapeutics Inc. (DMAC) worth $343,500, representing 0.03% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Private Capital has initiated a new position in DMAC, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Private Capital's DiaMedica Therapeutics (DMAC) Holding Value Over Time
Track share changes against reported price movement
Quarterly DiaMedica Therapeutics (DMAC) Trades by Private Capital
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +50,000 | New Buy | 50,000 | $6.87 |
Private Capital's DiaMedica Therapeutics Investment FAQs
Private Capital first purchased DiaMedica Therapeutics Inc. (DMAC) in Q3 2025, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital has held DiaMedica Therapeutics Inc. (DMAC) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital's largest addition to DiaMedica Therapeutics Inc. (DMAC) was in Q3 2025, adding 50,000 shares worth $343,500. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Private Capital's firm, Private Capital Management, LLC, owns 50,000 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $343,500. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, DiaMedica Therapeutics Inc. (DMAC) represents approximately 0.03% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital's peak holding in DiaMedica Therapeutics Inc. (DMAC) was 50,000 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.